Inventor · disambiguated record
Jason Edward Brittain
Also filed as: BRITTAIN JASON · BRITTAIN JASON E · BRITTAIN JASON EDWARD
9 granted patents·11 pending applications·129 citations·filing 2005–2022
88Inventor score
Files withCEPHALON INC7BRITTAIN JASON EDWARD5SANOFI SA2AEOLUS SCIENCES INC1AMIRA PHARMACEUTICALS INC1
Top patents by PatentIndex Score
20 records- 0195US8791270B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2013·Granted Jul 29, 2014·31 cites·23 claims
- 0294US8461350B2Bendamustine pharmaceutical compositionsBRITTAIN JASON EDWARD·Filed 2012·Granted Jun 11, 2013·36 cites·14 claims
- 0393US8609863B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2012·Granted Dec 17, 2013·21 cites·4 claims
- 0493US8436190B2Bendamustine pharmaceutical compositionsBRITTAIN JASON EDWARD·Filed 2006·Granted May 7, 2013·28 cites·9 claims
- 0591US8895756B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2012·Granted Nov 25, 2014·13 cites·4 claims
- 0670US2023322657A1Crystalline edg-2 receptor antagonist and methods of makingSANOFI SA·Filed 2021·Application pending·0 cites
- 0770US2020237726A1Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2019·Application pending·0 cites
- 0866US2018296534A1Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2018·Application pending·0 cites
- 0964US2014148490A1Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2014·Application pending·0 cites
- 1063US2022064105A1Crystalline edg-2 receptor antagonist and methods of makingSANOFI SA·Filed 2021·Application pending·0 cites
- 1158US2015374671A1Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2015·Application pending·0 cites
- 1257US9572785B2DP2 antagonist and uses thereofBRICKELL BIOTECH INC·Filed 2014·Granted Feb 21, 2017·0 cites·13 claims
- 1354US9556133B2Polycyclic LPA1 antagonist and uses thereofBRITTAIN JASON EDWARD·Filed 2011·Granted Jan 31, 2017·0 cites·2 claims
- 1454US2023181527A1Apical sodium-dependent transporter inhibitor compositionsMIRUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1551US2017121295A1Polycyclic lpa1 antagonist and uses thereofAMIRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1650US8815917B2DP2 antagonist and uses thereofBRITTAIN JASON EDWARD·Filed 2010·Granted Aug 26, 2014·0 cites·5 claims
- 1750US2021290644A1Compounds and methods for treating fungal infectionsAMPLYX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1846US2006041013A1Alanosine formulations and methods of useBRITTAIN JASON E·Filed 2005·Application pending·0 cites
- 1945US9688624B2DP2 antagonist and uses thereofBRITTAIN JASON EDWARD·Filed 2011·Granted Jun 27, 2017·0 cites·11 claims
- 2035US2016333019A1Synthesis and formulations of porphyrin compoundsAEOLUS SCIENCES INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Edward Brittain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →